{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T05:33:12Z","timestamp":1793251992662,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejphar.2026.179446","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:54:32Z","timestamp":1792684472000},"page":"179446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting PGAM1 overcomes paclitaxel resistance and restores cuproptosis sensitivity in non-small cell lung cancer"],"prefix":"10.1016","volume":"1039","author":[{"given":"Zhansheng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiru","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duo","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusheng","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanting","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.179446_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70197","article-title":"USP18 confers paclitaxel resistance in non-small cell lung cancer by stabilizing SHANK1 expression via deubiquitination","volume":"39","author":"Chai","year":"2025","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.ejphar.2026.179446_bib2","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/s41417-025-00976-8","article-title":"SMAD4-armed oncolytic adenovirus therapy potentiates the chemotherapy effects in NSCLC through suppression of the Wnt\/\u03b2-catenin pathway","volume":"32","author":"Dai","year":"2025","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.ejphar.2026.179446_bib3","doi-asserted-by":"crossref","first-page":"504","DOI":"10.62641\/aep.v53i3.1773","article-title":"Activation of the oxytocin system in the hypothalamic paraventricular nucleus improves stress-induced postpartum depression-like behavior in rats","volume":"53","author":"Dang","year":"2025","journal-title":"Actas Esp. Psiquiatr."},{"key":"10.1016\/j.ejphar.2026.179446_bib4","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.3390\/curroncol30030228","article-title":"Cuproptosis-related gene DLAT as a novel biomarker correlated with prognosis, chemoresistance, and immune infiltration in pancreatic adenocarcinoma: a preliminary study based on bioinformatics analysis","volume":"30","author":"Fang","year":"2023","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.ejphar.2026.179446_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2024.116807","article-title":"ALKBH5 regulates paclitaxel resistance in NSCLC via inhibiting CEMIP-Mediated EMT","volume":"483","author":"Gao","year":"2024","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179446_bib6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41392-025-02192-0","article-title":"The molecular mechanism and therapeutic landscape of copper and cuproptosis in cancer","volume":"10","author":"Guo","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2026.179446_bib7","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.62641\/aep.v53i6.2085","article-title":"Analysis of the development trajectory and influencing factors of depression in patients with cervical cancer during concurrent chemoradiotherapy","volume":"53","author":"He","year":"2025","journal-title":"Actas Esp. Psiquiatr."},{"key":"10.1016\/j.ejphar.2026.179446_bib8","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.cmet.2019.09.014","article-title":"A novel allosteric inhibitor of phosphoglycerate mutase 1 suppresses growth and metastasis of non-small-cell lung cancer","volume":"30","author":"Huang","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejphar.2026.179446_bib9","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4209475","article-title":"GSK-3\u03b2 at the intersection of neuronal plasticity and neurodegeneration","volume":"2019","author":"Jaworski","year":"2019","journal-title":"Neural Plast."},{"key":"10.1016\/j.ejphar.2026.179446_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262110278","article-title":"Circulating molecular biomarkers for the diagnosis and monitoring of NSCLC-A review","volume":"26","author":"Jelski","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179446_bib11","first-page":"278","article-title":"The epidemiological landscape of lung cancer: current status, temporal trend and future projections based on the latest estimates from GLOBOCAN 2022","volume":"5","author":"Ji","year":"2025","journal-title":"J. Natl. Cancer Cent."},{"key":"10.1016\/j.ejphar.2026.179446_bib12","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1002\/ijc.28637","article-title":"The role of phosphoglycerate mutase 1 in tumor aerobic glycolysis and its potential therapeutic implications","volume":"135","author":"Jiang","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejphar.2026.179446_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117415","article-title":"Baicalein enhances cisplatin sensitivity in cervical cancer cells by promoting cuproptosis through the akt pathway","volume":"179","author":"Jin","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2026.179446_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14196960","article-title":"Update on the treatment of non-small cell lung carcinoma (NSCLC)","volume":"14","author":"Kariri","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ejphar.2026.179446_bib15","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.2147\/OTT.S238920","article-title":"Phosphoglycerate mutase 1: its glycolytic and non-glycolytic roles in tumor malignant behaviors and potential therapeutic significance","volume":"13","author":"Li","year":"2020","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ejphar.2026.179446_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100957","article-title":"A phosphoglycerate mutase 1 allosteric inhibitor overcomes drug resistance to EGFR-targeted therapy via disrupting IL-6\/JAK2\/STAT3 signaling pathway in lung adenocarcinoma","volume":"68","author":"Liang","year":"2023","journal-title":"Drug Resist. Updates : reviews and commentaries in antimicrobial and anticancer chemotherapy"},{"key":"10.1016\/j.ejphar.2026.179446_bib17","article-title":"NFE2L2 and SLC25A39 drive cuproptosis resistance through GSH metabolism","volume":"14","author":"Liu","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.179446_bib18","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/s41418-024-01341-2","article-title":"Dysregulated Wnt\/\u03b2-catenin signaling confers resistance to cuproptosis in cancer cells","volume":"31","author":"Liu","year":"2024","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejphar.2026.179446_bib19","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.cell.2011.03.054","article-title":"Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1","volume":"145","author":"Luo","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2026.179446_bib20","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1039\/D5CS00083A","article-title":"Cuproptosis: mechanisms and nanotherapeutic strategies in cancer and beyond","volume":"54","author":"Mao","year":"2025","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejphar.2026.179446_bib21","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.1158\/0008-5472.CAN-18-0187","article-title":"Projections in breast and lung cancer mortality among women: a bayesian analysis of 52 countries worldwide","volume":"78","author":"Mart\u00edn-S\u00e1nchez","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2026.179446_bib22","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1517\/14656566.3.6.755","article-title":"Paclitaxel in cancer therapy","volume":"3","author":"Mekhail","year":"2002","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.ejphar.2026.179446_bib23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-3-319-57127-0_6","article-title":"Clinical development of anti-mitotic drugs in cancer","volume":"1002","author":"Olziersky","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejphar.2026.179446_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/cells9102308","article-title":"Cancer metabolism: phenotype, signaling and therapeutic targets","volume":"9","author":"Park","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2026.179446_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/cells11020219","article-title":"TFEB regulates ATP7B expression to promote platinum chemoresistance in human ovarian cancer cells","author":"Petruzzelli","year":"2022","journal-title":"Cells 11"},{"key":"10.1016\/j.ejphar.2026.179446_bib26","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1186\/s12885-022-10164-8","article-title":"NOVA1 promotes NSCLC proliferation and invasion by activating Wnt\/\u03b2-catenin signaling","volume":"22","author":"Qu","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejphar.2026.179446_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1342086","article-title":"NSCLC: from tumorigenesis, immune checkpoint misuse to current and future targeted therapy","volume":"15","author":"Raskova Kafkova","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2026.179446_bib28","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.molcel.2011.02.007","article-title":"Clk 2 and B56\u03b2 mediate insulin-regulated assembly of the PP2A phosphatase holoenzyme complex on Akt","volume":"41","author":"Rodgers","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejphar.2026.179446_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103567","article-title":"Suppression of the LKB1-AMPK-SLC7A11-GSH signaling pathway sensitizes NSCLC to albumin-bound paclitaxel via oxidative stress","volume":"81","author":"Rong","year":"2025","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2026.179446_bib30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0093-7754(01)90058-2","article-title":"Predicting response to paclitaxel\/carboplatin-based therapy in non-small cell lung cancer","volume":"28","author":"Rosell","year":"2001","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.ejphar.2026.179446_bib31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.path.2019.11.002","article-title":"Targeted therapy and checkpoint immunotherapy in lung cancer","volume":"13","author":"Ruiz-Cordero","year":"2020","journal-title":"Surg. Pathol. Clin."},{"key":"10.1016\/j.ejphar.2026.179446_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26052049","article-title":"Lung cancer-epidemiology, pathogenesis, treatment and molecular aspect (Review of literature)","volume":"26","author":"Smolarz","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179446_bib33","doi-asserted-by":"crossref","first-page":"791","DOI":"10.62641\/aep.v53i4.1921","article-title":"The mediating role of depression in the association between death anxiety and quality of life in elderly prostate cancer patients","volume":"53","author":"Song","year":"2025","journal-title":"Actas Esp. Psiquiatr."},{"key":"10.1016\/j.ejphar.2026.179446_bib34","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a007898","article-title":"The \u03b2-catenin destruction complex","volume":"5","author":"Stamos","year":"2013","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.ejphar.2026.179446_bib35","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1038\/s41467-023-42025-8","article-title":"Lactylation of METTL16 promotes cuproptosis via m(6)A-modification on FDX1 mRNA in gastric cancer","volume":"14","author":"Sun","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.179446_bib36","article-title":"AKT1 phosphorylates FDX1 to promote cuproptosis resistance in triple-negative breast cancer","volume":"12","author":"Sun","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.ejphar.2026.179446_bib37","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1083\/jcb.201808077","article-title":"Anti-mitotic therapies in cancer","volume":"218","author":"Tischer","year":"2019","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejphar.2026.179446_bib38","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1200\/JCO.2012.46.9270","article-title":"New pathologic classification of lung cancer: relevance for clinical practice and clinical trials","volume":"31","author":"Travis","year":"2013","journal-title":"J. Clin. Oncol. : official journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.ejphar.2026.179446_bib39","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cellsig.2010.08.003","article-title":"The diverse functions of GAPDH: views from different subcellular compartments","volume":"23","author":"Tristan","year":"2011","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejphar.2026.179446_bib40","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.ejphar.2026.179446_bib41","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1007\/s12033-023-00865-1","article-title":"CircRNA PGAM1 promotes the migration and invasion of pancreatic adenocarcinoma cells by activating the AKT\/mTOR signaling pathway","volume":"66","author":"Wang","year":"2024","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.ejphar.2026.179446_bib42","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12592","article-title":"Rab 25 promotes erlotinib resistance by activating the \u03b21 integrin\/AKT\/\u03b2-catenin pathway in NSCLC","volume":"52","author":"Wang","year":"2019","journal-title":"Cell Prolif."},{"key":"10.1016\/j.ejphar.2026.179446_bib43","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s13046-021-02119-x","article-title":"An SETD1A\/Wnt\/\u03b2-catenin feedback loop promotes NSCLC development","volume":"40","author":"Wang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res. : CR"},{"key":"10.1016\/j.ejphar.2026.179446_bib44","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.bbrc.2020.05.135","article-title":"miR-149 contributes to resistance of 5-FU in gastric cancer via targeting TREM2 and regulating \u03b2-catenin pathway","volume":"532","author":"Wang","year":"2020","journal-title":"BBRC (Biochem. Biophys. Res. Commun.)"},{"key":"10.1016\/j.ejphar.2026.179446_bib45","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12672-025-01939-z","article-title":"PGAM1: a potential therapeutic target mediating Wnt\/\u03b2-catenin signaling drives breast cancer progression","volume":"16","author":"Wang","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.ejphar.2026.179446_bib46","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1098\/rstb.1981.0066","article-title":"Structure and activity of phosphoglycerate mutase","volume":"293","author":"Winn","year":"1981","journal-title":"Phil. Trans. Roy. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.ejphar.2026.179446_bib47","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12943-023-01732-y","article-title":"Cuproptosis: mechanisms and links with cancers","volume":"22","author":"Xie","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejphar.2026.179446_bib48","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/s41418-023-01125-0","article-title":"Cuproptosis: p53-regulated metabolic cell death?","volume":"30","author":"Xiong","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejphar.2026.179446_bib49","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1002\/ptr.70017","article-title":"Dihydrotanshinone I targets PGAM1 to induce SYVN1-Mediated ubiquitination and suppress glycolysis in hepatocellular carcinoma","volume":"39","author":"Xu","year":"2025","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejphar.2026.179446_bib50","doi-asserted-by":"crossref","first-page":"422","DOI":"10.62641\/aep.v53i2.1949","article-title":"Effects of mindfulness therapy on breast cancer patients with depression or anxiety: a systematic review and meta-analysis","volume":"53","author":"Yan","year":"2025","journal-title":"Actas Esp. Psiquiatr."},{"key":"10.1016\/j.ejphar.2026.179446_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114798","article-title":"Targeting PGAM1 in cancer: an emerging therapeutic opportunity","volume":"244","author":"Yang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.179446_bib52","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature10598","article-title":"Nuclear PKM2 regulates \u03b2-catenin transactivation upon EGFR activation","volume":"480","author":"Yang","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2026.179446_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.724","article-title":"Copper homeostasis and cuproptosis in health and disease","volume":"5","author":"Yang","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.ejphar.2026.179446_bib54","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1038\/onc.2016.446","article-title":"Phosphoglycerate mutase 1 promotes cancer cell migration independent of its metabolic activity","volume":"36","author":"Zhang","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2026.179446_bib55","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12935-025-03683-4","article-title":"Cuproplasia and cuproptosis in hepatocellular carcinoma: mechanisms, relationship and potential role in tumor microenvironment and treatment","volume":"25","author":"Zhang","year":"2025","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ejphar.2026.179446_bib56","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1186\/s12967-024-05380-8","article-title":"Wnt\/\u03b2-catenin signaling in the development and therapeutic resistance of non-small cell lung cancer","volume":"22","author":"Zhang","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejphar.2026.179446_bib57","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10863-021-09875-7","article-title":"GOLM1 predicts poor prognosis of patients with NSCLC and is associated with the proliferation and chemo-sensitivity of cisplatin in NSCLC cells: bioinformatics analysis and laboratory validation","volume":"53","author":"Zhao","year":"2021","journal-title":"J. Bioenerg. Biomembr."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926009283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926009283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T05:03:36Z","timestamp":1793250216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926009283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":57,"alternative-id":["S0014299926009283"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179446","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting PGAM1 overcomes paclitaxel resistance and restores cuproptosis sensitivity in non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179446","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"179446"}}